Funders and Partners
PROTECT-C is run under the leadership of Professor Ranjit Manchanda, the Chief Investigator of the study, and coordinated by the Barts Clinical Trials Unit at Queen Mary University of London (QMUL).
The study is funded by Yorkshire Cancer Research.
PROTECT-C is a huge broad-based effort bringing together researchers based across several leading national and international centres. These include:
Queen Mary University of London (QMUL), UK
University of Manchester, UK
Institute of Cancer Research, UK
London School of Hygiene & Tropical Medicine, UK
University of Oxford, UK
Leeds Institute for Molecular Medicine, UK
RCGP Clinical Champion for Genomics in Primary Care Programme, UK
University of Leeds, UK
Edinburgh Cancer Research Centre, UK
VU University Medical Center Amsterdam, The Netherlands
University College London (UCL), UK
Manchester Centre for Genomic Medicine, UK
St George’s University of London, UK
University of Cambridge, UK
Collaborations
UBQO Ltd (via their Clinibee platform) has supported the technical development of the PROTECT-C web-app.
Everything Genetic Ltd has provided the saliva collection kits and will perform the genetic test at an accredited laboratory.
Charities and Patient Groups
PROTECT-C is supported by a number of charity and patient representative groups.
